|
|
|
Preparations and Recommended Dosing Regimens for Antimicrobial Agents |
|
|
1 | (16) |
|
Preferred Antimicrobial Agents for Specific Pathogens |
|
|
17 | (22) |
|
Antimicrobial Dosing Regimens in Renal Failure |
|
|
39 | (18) |
|
Use of Antimicrobial Agents in Hepatic Disease |
|
|
57 | (1) |
|
Adverse Reactions to Antimicrobial Agents |
|
|
58 | (21) |
|
|
79 | (14) |
|
|
|
Adult Immunization Schedule |
|
|
93 | (31) |
|
Prophylactic Antibiotics in Surgery |
|
|
124 | (9) |
|
Antimicrobial Prophylaxis in Ambulatory Patients |
|
|
133 | (5) |
|
Prevention of Bacterial Endocarditis |
|
|
138 | (3) |
|
Prevention of Diseases Associated with Travel |
|
|
141 | (6) |
|
|
|
Treatment of Fungal Infections |
|
|
147 | (15) |
|
Treatment of Mycobacterial Infections |
|
|
162 | (12) |
|
Drugs for Treatment of Parasitic Infections |
|
|
174 | (17) |
|
Treatment of Viral Infections |
|
|
191 | (13) |
|
|
|
Sepsis and Sepsis Syndrome |
|
|
204 | (2) |
|
|
206 | (5) |
|
Toxic Shock Syndrome: Case Definition of CDC |
|
|
211 | (1) |
|
Group A Streptococcal Infections |
|
|
212 | (1) |
|
|
213 | (1) |
|
|
214 | (2) |
|
Treatment of Lyme Disease and Potential Exposures |
|
|
216 | (3) |
|
Infections of Epidermis, Dermis, and Subcutaneous Tissue |
|
|
219 | (4) |
|
Deep Serious Soft Tissue Infections |
|
|
223 | (1) |
|
Bone and Joint Infections |
|
|
224 | (5) |
|
Ocular and Periocular Infections |
|
|
229 | (4) |
|
Infections of Central Nervous System |
|
|
233 | (10) |
|
Upper Respiratory Tract Infections |
|
|
243 | (7) |
|
|
250 | (6) |
|
|
256 | (8) |
|
|
264 | (3) |
|
Intra-Abdominal Sepsis: Antibiotic Selection |
|
|
267 | (3) |
|
Helicobacter Pylori: Treatment of Peptic Ulcer Disease |
|
|
270 | (1) |
|
|
271 | (8) |
|
|
279 | (5) |
|
|
284 | (4) |
|
Sexually Transmitted Diseases |
|
|
288 | (18) |
|
Duration of Antibiotic Treatment |
|
|
306 | (3) |
|
Trade Names of Antimicrobial Agents |
|
|
309 | (4) |
Index |
|
313 | |